Abstract
Synthetic oligodeoxyribonucleotides (ODN) have been proposed as a class of potential therapeutic agents that can interact in a rational way with DNA or RNA, with the aim of inhibiting the expression of unwanted genetic information (, , ). One of the most critical questions in the evaluation of these molecules, is their stability toward enzymatic breakdown by [3′ or 5′]-exonucleases and endonucleases (). In order to inhibit or at least limit the effect of these nucleases, chemically modified ODNs have been synthesized.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
